Prostate Cancer UK appoints new CEO
After a rigorous recruitment process, the Board of Trustees has appointed Angela Culhane as Prostate Cancer UK's new Chief Executive.
Prostate Cancer UK has appointed Angela Culhane as its new Chief Executive.
Angela, who joined us in January 2014, had been acting as interim CEO since October last year, having stepped up from her role as the charity’s Director of Finance.
William Russell, Chairman of the Prostate Cancer UK Board of Trustees said:
“The Trustees have been conducting a rigorous recruitment process over a number of months and the Board is now able to confirm that we have found the right person for the role. I am delighted that it is Angela Culhane, our current interim CEO and former Director of Finance.
Angela has done a great job as interim CEO over the past four months; she balances the focus on value and good governance which comes naturally with her strong finance and commercial background, with energy and a real passion for Prostate Cancer UK’s aims. I have every confidence that Angela will provide the leadership the charity needs as it embarks on the next exciting phase with the launch of our 10 year strategy to stop prostate cancer being a killer.”
The new CEO’s first task upon appointment was to unveil our new action plan, ‘Ten Years to Tame Prostate Cancer’, at a gathering of top clinicians and scientists, chaired by Prof Robert Winston, at London’s City Hall.
Angela lives in Colchester and has strong personal reasons for wanting to take a lead in the fight against prostate cancer. Her stepfather died of the disease, as did her husband’s father and grandfather.
It’s both a privilege and a challenge to lead the team which has such decisive plans to shift the science and make prostate cancer a disease the next generation need not fear.
“One of the risk factors of prostate cancer is having a close male relative who had it. With generations of the disease behind them, my husband and my son are both in that higher risk group.
“With one man dying of prostate cancer every single hour in the UK, it touches so many families just as it has touched mine. It’s both a privilege and a challenge to lead the team which has such decisive plans to shift the science and make prostate cancer a disease the next generation need not fear. If I can play my part in achieving this, I’ll be extremely proud,” said Culhane.
Angela Culhane replaces former CEO Owen Sharp, who left the charity last autumn to work with Prostate Cancer UK’s close partner the Movember Foundation.